Cero Therapeutics Holdings Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,460 | 1,670 | -9,150 | -3,920 | -540 |
| Depreciation Amortization | 1,400 | 1,030 | 620 | 2,210 | 1,690 |
| Other Working Capital | 11,420 | -5,880 | 5,170 | -3,110 | -4,570 |
| Other Operating Activity | 3,980 | 40 | 2,150 | 1,650 | 1,150 |
| Operating Cash Flow | $-1,660 | $-3,140 | $-1,210 | $-3,170 | $-2,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -980 | -2,420 | -470 | -3,850 | -3,480 |
| Other Investing Activity | 2,590 | 3,560 | 4,550 | 5,600 | 3,360 |
| Investing Cash Flow | $1,610 | $1,140 | $4,080 | $1,750 | $-120 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 30 | 670 | 3 | 920 | 730 |
| Financing Cash Flow | $30 | $670 | $3 | $920 | $730 |
| Beginning Cash Position | 1,610 | 2,100 | 1,610 | 2,100 | 2,100 |
| End Cash Position | 1,590 | 780 | 4,480 | 1,610 | 440 |
| Net Cash Flow | $-10 | $-1,320 | $2,870 | $-490 | $-1,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,660 | -3,140 | -1,210 | -3,170 | -2,270 |
| Free Cash Flow | -1,660 | -3,140 | -1,210 | -3,170 | -2,270 |